Skip to main content

Advertisement

Advertisement

ADVERTISEMENT

August 2015 - FRMC

09/24/2015

Jill Sederstrom

Jill Sederstrom
Certain factors have been shown to lead to better outcomes 
Certain factors have been shown to lead to better outcomes 
Certain factors have been...
09/24/2015
First Report Managed Care
09/24/2015
Jill Sederstrom
Jill Sederstrom
Fewer complications occur when patients with diabetes have simultaneous control of A1c values, blood pressure (BP), and low-density lipoprotein (LDL). According to a session at CRS, it is possible to achieve all 3 aims in a primary care...
Fewer complications occur when patients with diabetes have simultaneous control of A1c values, blood pressure (BP), and low-density lipoprotein (LDL). According to a session at CRS, it is possible to achieve all 3 aims in a primary care...
Fewer complications occur when...
09/24/2015
First Report Managed Care
09/24/2015

Mary Beth Nierengarten

Mary Beth Nierengarten
Europe and other countries lead the US in bringing biosimilars to market, according to Steven Miller, MD, vice president, chief medical officer, Express Scripts.
Europe and other countries lead the US in bringing biosimilars to market, according to Steven Miller, MD, vice president, chief medical officer, Express Scripts.
Europe and other countries lead...
09/24/2015
First Report Managed Care
09/24/2015
Eileen Koutnik-Fotopoulos
Eileen Koutnik-Fotopoulos
Outcomes from 2 major cardiovascular (CV) trials of the DPP-4 inhibitor sitagliptin and the glucagon- GLP-1 receptor agonist lixisenatide were presented at the ADA meeting.
Outcomes from 2 major cardiovascular (CV) trials of the DPP-4 inhibitor sitagliptin and the glucagon- GLP-1 receptor agonist lixisenatide were presented at the ADA meeting.
Outcomes from 2 major...
09/24/2015
First Report Managed Care
09/24/2015
Eileen Koutnik-Fotopoulos
Eileen Koutnik-Fotopoulos
Many individuals with diabetes have suboptimal HbA1c control. Adding more than 2 to 3 oral medications may not achieve glycemic targets, and adherence is not always optimal.
Many individuals with diabetes have suboptimal HbA1c control. Adding more than 2 to 3 oral medications may not achieve glycemic targets, and adherence is not always optimal.
Many individuals with diabetes...
09/24/2015
First Report Managed Care
09/08/2015
NULL
NULL
Boston, MA—Individuals with diabetes are more than twice as likely to face depression or varying degrees of mental health issues as individuals without the disease. Data from the World Health Organization (WHO) shows that mental health...
Boston, MA—Individuals with diabetes are more than twice as likely to face depression or varying degrees of mental health issues as individuals without the disease. Data from the World Health Organization (WHO) shows that mental health...
Boston, MA—Individuals with...
09/08/2015
First Report Managed Care

Department

Conference Insider
09/24/2015

Eileen Koutnik-Fotopoulos

Eileen Koutnik-Fotopoulos
Nursing home residents often experience avoidable inpatient hospitalizations.
Nursing home residents often experience avoidable inpatient hospitalizations.
Nursing home residents often...
09/24/2015
First Report Managed Care
Conference Insider
09/24/2015

Mary Mihalovic

Mary Mihalovic
Psoriatic disease is now understood to be a systemic condition with a link to cardiometabolic risk as well as other comorbidities, including some types of cancers.
Psoriatic disease is now understood to be a systemic condition with a link to cardiometabolic risk as well as other comorbidities, including some types of cancers.
Psoriatic disease is now...
09/24/2015
First Report Managed Care
Conference Insider
09/24/2015

Mary Mihalovic

Mary Mihalovic
How do findings from clinical trials differ from actual clinical practice in the treatment of immune-mediated inflammatory diseases (IMIDs)? And what are the implications? Three experts answered those questions during a presentation from IAS.
How do findings from clinical trials differ from actual clinical practice in the treatment of immune-mediated inflammatory diseases (IMIDs)? And what are the implications? Three experts answered those questions during a presentation from IAS.
How do findings from clinical...
09/24/2015
First Report Managed Care

Column

Viewpoint
09/24/2015

Richard G. Fried, MD, PhD

Richard G. Fried, MD, PhD
Both clinicians and patients living with psoriasis know that this chronic and capricious disease can have deleterious effects on the psyche.
Both clinicians and patients living with psoriasis know that this chronic and capricious disease can have deleterious effects on the psyche.
Both clinicians and patients...
09/24/2015
First Report Managed Care

Advertisement

Advertisement

Advertisement